Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | PRESSURE BIOSCIENCES INC - 8-K, Current Report | 1 | SEC Filings | ||
11.04. | Pressure BioSciences, Inc.: Uncle Bud's Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness | 1 | GlobeNewswire (USA) | ||
02.04. | Pressure BioSciences, Inc.: Pressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray - First Product in New "Premium Collection" | 1 | GlobeNewswire (USA) | ||
01.04. | PRESSURE BIOSCIENCES INC - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
26.02. | Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc. | 1 | GlobeNewswire (USA) | ||
15.02. | Pressure BioSciences, Inc.: Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing | 345 | GlobeNewswire (Europe) | CANTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBIO" or the "Company"), a leading innovator in high-pressure nanotechnology and a pioneer in the development... ► Artikel lesen | |
05.02. | Pressure BioSciences, Inc.: Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness | 203 | GlobeNewswire (Europe) | Multi-Patented Nanoemulsification Platform Enables Wide-Range of Best-in-Class Health and Wellness Products - Revenue Impact of $5 Million in 2024 Anticipated with Further Acceleration in 2025 & Beyond... ► Artikel lesen | |
25.01. | PRESSURE BIOSCIENCES INC - 8-K, Current Report | - | SEC Filings | ||
22.01. | Pressure BioSciences, Inc.: Pressure BioSciences Announces Closing of Uncle Bud's Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales | 1 | GlobeNewswire (USA) | ||
18.01. | Pressure BioSciences, Inc.: Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order | 160 | GlobeNewswire (Europe) | SOUTH EASTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based... ► Artikel lesen | |
16.01. | Pressure BioSciences, Inc.: Pressure BioSciences' New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January | 1 | GlobeNewswire (USA) | ||
11.01. | Pressure BioSciences To Acquire Uncle Bud's | 1 | RTTNews | ||
11.01. | Pressure Biosciences to acquire wellness firm Uncle Bud's in an all stock deal | 1 | Seeking Alpha | ||
04.01. | Pressure BioSciences Inc.: Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational Technologies | 268 | ACCESSWIRE | Artificial Intelligence/Machine Learning Also Expected to Significantly Accelerate Advancements in PBIO's Patented, Innovative, and Enabling UltraShear Processing PlatformSOUTH EASTON, MA / ACCESSWIRE... ► Artikel lesen | |
21.12.23 | Pressure BioSciences Inc.: Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform | 149 | ACCESSWIRE | Beyond Formidable Enhancements for the Food and Beverage Industry, UST Offers Promising Applications in Drug Delivery, Cosmetics, Biotechnology, Agriculture, and Advanced NanomaterialsSOUTH EASTON,... ► Artikel lesen | |
12.12.23 | Pressure BioSciences Inc.: Pressure BioSciences' UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores | 332 | ACCESSWIRE | Novel Results Published in Respected Peer-Reviewed Food Science and Emerging Technologies Journal - Discussions Underway with Beverage Industry CompaniesSOUTH EASTON, MA / ACCESSWIRE / December 12,... ► Artikel lesen | |
01.12.23 | Pressure BioSciences Inc.: Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador | 368 | ACCESSWIRE | Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of the Agreement. "Valor CBD" Topical Spray Now Available on the VST Website.SOUTH EASTON, MA /... ► Artikel lesen | |
22.11.23 | Pressure BioSciences GAAP EPS of -$0.29, revenue of $0.41M | 4 | Seeking Alpha | ||
21.11.23 | Pressure BioSciences Inc.: Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023 | 293 | ACCESSWIRE | Investor Call Scheduled for Tuesday, November 21, 2023 at 4:30 p.m. ETSOUTH EASTON, MA / ACCESSWIRE / November 21, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in... ► Artikel lesen | |
20.11.23 | PRESSURE BIOSCIENCES INC - 10-Q, Quarterly Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MOUNTAIN VALLEY MD | 0,041 | -4,21 % | Mountain Valley MD Holdings Inc: Mountain Valley licenses Agrarius plant signalling tech | ||
CYTOSORBENTS | 0,750 | -0,13 % | CytoSorbents to Report First Quarter 2024 Operating and Financial Results | ||
QUEST DIAGNOSTICS | 128,60 | +1,82 % | Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity | Foundation grant will help NYC-based nonprofit expand reach of its innovative curriculum to 50 schools in Baltimore and Houston; funding will also support film screening tour of award-winning documentary... ► Artikel lesen | |
CENTENE | 67,83 | -3,84 % | Centene-Aktie legt um 0,84 Prozent zu (71,0929 €) | Im Plus liegt aktuell das Wertpapier von Centene . Das Papier kostete zuletzt 75,78 US-Dollar. Heute hat sich an der US-amerikanischen Börse die Centene-Aktie zwischenzeitlich um 0,84 Prozent verteuert.... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,76 | +0,88 % | Dividendenbekanntmachungen (19.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABG SUNDAL COLLIER HOLDING ASA NO0003021909 0,5 NOK 0,0425 EUR ALM BRAND A/S DK0015250344 0,55 DKK 0,0737 EUR APA CORPORATION US03743Q1085 0... ► Artikel lesen | |
FRESENIUS | 27,260 | +0,29 % | Fresenius: Aktie knackt Hürde - wichtige Termine voraus | Die Aktie von Fresenius kommt immer mehr in Fahrt. Am heutigen Montag gewinnt das Papier weitere 1,2 Prozent auf 27,21 Euro, nachdem Fresenius in den vergangenen Wochen bereits deutlich zulegen konnte.... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,410 | -1,01 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC vor Quartalszahlen auf "Underweight" mit einem Kursziel von 35,40 Euro belassen. Nach einem Gespräch mit der Investor-Relations-Abteilung... ► Artikel lesen | |
CARL ZEISS MEDITEC | 99,85 | +0,86 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
GERRESHEIMER | 100,20 | +1,01 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
CASTLE BIOSCIENCES | 19,510 | 0,00 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen | |
M1 KLINIKEN | 13,200 | +4,76 % | EQS-Adhoc: M1 Kliniken AG beschließt Aktienrückkauf | EQS-Ad-hoc: M1 Kliniken AG / Schlagwort(e): Aktienrückkauf
M1 Kliniken AG beschließt Aktienrückkauf
26.04.2024 / 11:06 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17... ► Artikel lesen | |
ECKERT & ZIEGLER | 36,540 | +1,39 % | Eckert & Ziegler gutes Q1 - reicht zumindest für Prognosebestätigung. Und Kursfeuerwerk. Eintagsfliege? | Eckert & Ziegler (ISIN: DE0005659700) - Anfang Januar noch beim Platow Brief als klarer KAUF eingestuft - liefert heute im Rahmen einer ad-hoc-Meldung einen vorläufigen Blick auf die Q1-Zahlen, die... ► Artikel lesen | |
STRATEC | 41,700 | +3,86 % | Minimale Kursveränderung bei Stratec-Aktie (40,00 €) | Der Kurs der dem Anteilsschein von Stratec kommt kaum von der Stelle. Zuletzt zahlten Investoren für das Wertpapier 40,00 Euro. Einen minimalen Wertverlust von 0,12 Prozent zeigt die Kurstafel für die... ► Artikel lesen | |
NANO-X IMAGING | 8,940 | +0,22 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
GOODRX | 7,210 | +1,84 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen |